Changchun ProteLight Pharmaceutical & Biotechnology Co., Ltd. was established in 2006. It is mainly engaged in the preclinical research of peptide drugs and chemical drugs as well as the research and development of innovative disinfection products. It is a wholly-owned R&D subsidiary of Jiangsu ProteLight Pharmaceutical & Biotechnology Co., Ltd. The company is located in Changchun High-tech Development Zone and is a national high-tech enterprise.
Since its establishment, the company has undertaken the “12th Five-Year”major science and technology project of the National Health Commission’s "Major New Drug Creation", the Ministry of Science and Technology SME Technology Innovation Fund, the Jilin Province’s “International Science and Technology Cooperation Project”, and the Jilin Province’s “Special Fund Project for the Development of the Pharmaceutical and Health Industry”. The company also has been selected into the Jilin Province Science and Technology Department’s "Major Science and Technology Research Project", and the Jilin Province Science and Technology Innovation Talent Cultivation Plan’s "Youth Research Fund Project".
Changchun ProteLight takes innovation as the soul, takes improving the quality of life as its unremitting pursuit, takes scientific rigor as the code of conduct, upholds the research and development of innovative drugs as its mission, continuously develops high-quality new varieties for the head office, and creates a benign closed-loop operation model that pays equal attention to production processes, pilot trials, and R&D.